Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer.

Saved in:
Bibliographic Details
Title: Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer.
Authors: Hsu, Hung‐Chih1,2 (AUTHOR), Liu, Yu‐Chun2 (AUTHOR), Wang, Chuang‐Wei3,4 (AUTHOR), Chou, Wen-Chi1,2 (AUTHOR), Hsu, Yu-Jen2,5 (AUTHOR), Chiang, Jy-Ming2,5 (AUTHOR), Lin, Yung-Chang1,2 (AUTHOR), Yang, Tsai-Sheng1,2 (AUTHOR) a481124@cgmh.org.tw
Source: Cancer Medicine. Jul2019, Vol. 8 Issue 7, p3437-3446. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 137268186
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Hsu%2C+Hung‐Chih%22">Hsu, Hung‐Chih</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Yu‐Chun%22">Liu, Yu‐Chun</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Chuang‐Wei%22">Wang, Chuang‐Wei</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chou%2C+Wen-Chi%22">Chou, Wen-Chi</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hsu%2C+Yu-Jen%22">Hsu, Yu-Jen</searchLink><relatesTo>2,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chiang%2C+Jy-Ming%22">Chiang, Jy-Ming</searchLink><relatesTo>2,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+Yung-Chang%22">Lin, Yung-Chang</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Tsai-Sheng%22">Yang, Tsai-Sheng</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> a481124@cgmh.org.tw</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cancer+Medicine%22">Cancer Medicine</searchLink>. Jul2019, Vol. 8 Issue 7, p3437-3446. 10p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=137268186
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cam4.2235
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: 3437
    Titles:
      – TitleFull: Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hsu, Hung‐Chih
      – PersonEntity:
          Name:
            NameFull: Liu, Yu‐Chun
      – PersonEntity:
          Name:
            NameFull: Wang, Chuang‐Wei
      – PersonEntity:
          Name:
            NameFull: Chou, Wen-Chi
      – PersonEntity:
          Name:
            NameFull: Hsu, Yu-Jen
      – PersonEntity:
          Name:
            NameFull: Chiang, Jy-Ming
      – PersonEntity:
          Name:
            NameFull: Lin, Yung-Chang
      – PersonEntity:
          Name:
            NameFull: Yang, Tsai-Sheng
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: Jul2019
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 20457634
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Cancer Medicine
              Type: main
ResultId 1